Navigation Links
Moffitt Cancer Center researchers analyze how Spanish smoking relapse booklets are distributed
Date:5/16/2013

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre" ("Forever Free"), a Spanish smoking relapse prevention booklet series.

Their analysis found that 10 agencies distributed the booklets actively and passively, but those methods may not have helped the material reach its intended audience, Spanish-speaking smokers who have quit but are at risk for relapse.

Their study appeared in a March issue of the Journal of Cancer Education.

"Previous research suggests that although the current smoking rates among Hispanics are lower than the overall prevalence in the United States, Hispanic smokers are less likely to quit successfully or to use smoking cessation aids," said study co-author Vani Nath Simmons, Ph.D., assistant member of the Health Outcomes and Behavior Program at Moffitt. "Consequently, there is a great need to increase the availability of culturally relevant tobacco information in Spanish. The first aim of this study was to evaluate the distribution process of 'Libres para Siempre' to identify the strategies, methods and barriers to distribution. Secondly, we wanted feedback from the agencies on the booklets' quality and usefulness."

The researchers noted that the relapse rate for self-quitters is 95 to 98 percent and that Hispanic smokers are less likely than their non-Hispanic white counterparts to be advised to quit smoking.

"Forever Free," a series of self-help booklets developed at Moffitt to help smokers, who have quit from relapsing, was found to be cost effective and beneficial for reducing smoking relapse among English speakers. To increase its reach to more diverse populations, the "Forever Free" booklets were adapted to create a culturally appropriate Spanish version, "Libres para Siempre." This study examined how health care and social service agencies in Florida disseminated those Spanish booklets.

"To truly make an impact, we needed to make sure the booklets were getting into the hands of the intended audience," Simmons said.

Active distribution included in-person presentation of the booklets at community events or use of the booklet as part of counseling or tobacco-related classes. Passive distribution included displaying the booklet at agency lobbies, events and health fairs.

There were barriers to optimal distribution. For example, the booklets are a set of eight. Some agencies distributed booklets individually. Some distributors gave booklets to those who may have been interested in quitting smoking, rather than those who had quit and were likely to relapse. The booklets target those in danger of relapse.

"Understanding how these booklets are used in the real world can lead to future research to test alternative distribution strategies," noted Simmons. "We determined that some agencies were unable to understand the distinction between interventions for initial smoking cessation and intervention as relapse prevention."

In evaluating the quality and usefulness of the booklets, agency representatives found them beneficial for their clients.

The authors concluded that the distribution process for "Libres para Siempre" could serve as a pilot study to evaluate strategies and methods of distribution, and find the best ways to reach those Hispanics needing relapse prevention materials.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Cancer biorepository speeds clinical trials, drug development, Moffitt analysis shows
2. Deficiency in p53 anti-tumor protein delays DNA repair after radiation, Moffitt researchers say
3. Some minorities believe they are less likely to get cancer compared to whites, Moffitt study shows
4. 2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study shows
5. Moffitt Cancer Center researchers discuss new frontiers in breast cancer screening
6. Moffitt Cancer Center researchers say 1 specific microrna promotes tumor growth and cancer spread
7. Moffitt Researchers help lead international efforts that find new genetic links to ovarian cancer
8. Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
9. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
10. Genetic risk strategies needed for young, black, female breast cancer patients, Moffitt study shows
11. Moffitt Cancer Center researchers study use of dasatinib for patients with high-risk MDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... January 24, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... their head office and research site in Toronto, Canada. , Dr. Assadi’s extensive ...
(Date:1/23/2020)... Calif. (PRWEB) , ... January 23, 2020 , ... A ... chins and options to get rid of them. The article quotes the president of ... call a double-chin are many. They can be caused by a person’s facial structure ...
(Date:1/23/2020)... HUNTINGTON BEACH, Calif. (PRWEB) , ... January 23, 2020 , ... ... weaknesses in family dynamics came out strongly. Old family issues, rivalries, and secrets were ... holidays altogether. For many of those coping with addiction and their families, the holidays ...
(Date:1/23/2020)... ... 23, 2020 , ... Park Avenue based orthopedic surgeon Dr. Jeffrey Schildhorn ... to bring this new digital portal for patient education to his existing and future ... Temple University. With over 12 years of hands-on experience, Dr. Schildhorn has built his ...
(Date:1/23/2020)... ... January 23, 2020 , ... Relatient, ... Healthpac, a trusted medical billing software company for revenue cycle management (RCM) ... Healthpac’s customers can now access Relatient's latest solutions to improve the patient's ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... ... January 22, 2020 , ... Biodex ... software to U.S. customers. A total redesign of their legacy software, the modern ... functionality and intuitive navigation, while maintaining the testing and training accuracy they expect ...
(Date:1/22/2020)... ... 22, 2020 , ... Somatus, the market leader in providing ... groups, today announced it is expanding its renal management partnership with BlueCross BlueShield ... chronic kidney disease (CKD). This partnership previously only served BCBST’s Medicare Advantage members ...
(Date:1/22/2020)... N.J. (PRWEB) , ... January 22, 2020 , ... Natreon, ... (US 10,500,240) on Terminalia chebula. This newly granted patent expands Natreon’s strong patent portfolio ... , The primary claim in this patent is, “a method of treating osteoarthritis ...
Breaking Medicine Technology: